We previously identified two novel endogenous murine leukemia virus proviruses, PreXMRV-1 and PreXMRV-2, and showed that they most likely recombined during xenograft passaging of a human prostate tumor in mice to generate xenotropic murine leukemia virus-related virus (XMRV). To determine the recombination potential of PreXMRV-1 and PreXMRV-2, we examined the generation of replication-competent retroviruses (RCRs) over time in a cell culture system. We observed that either virus alone was noninfectious and the RNA transcripts of the viruses were undetectable in the blood and spleen of nude mice that carry them. To determine their potential to generate RCRs through recombination, we transfected PreXMRV-1 and PreXMRV-2 into 293T cells and used the virus produced to infect fresh cells; the presence of reverse transcriptase activity at 10 days postinfection indicated the presence of RCRs. Population sequencing of proviral DNA indicated that all RCRs contained the gag and 5= half of pol from PreXMRV-2 and the long terminal repeat, 3= half of pol (including integrase), and env from PreXMRV-1. All crossovers were within sequences of at least 9 identical nucleotides, and crossovers within each of two selected recombination zones of 415 nucleotides (nt) in the 5= untranslated region and 982 nt in pol were required to generate RCRs. A recombinant with the same genotype as XMRV was not detected, and our analysis indicates that the probability of generating an identical RCR is vanishingly small. In addition, the studies indicate that the process of RCR formation is primarily driven by selection for viable cis and trans elements from the parental proviruses.
E
ndogenous retroviruses (ERVs) are RNA viruses that have integrated their DNA copies into the genome of the host germ line. The integrated copy is passed down through successive generations and established as an endogenous element (1) . All vertebrates possess ERVs, and ERVs constitute ϳ10% of the mouse genome (2) . Murine ERVs are divided into three major categories: class I ERVs (0.68% of the murine genome) are closely related to gammaretroviruses, specifically, type C murine leukemia viruses (MLVs); class II ERVs (3.14% of the murine genome) include those that share close similarity to betaretroviruses, such as mouse mammary tumor virus and intracisternal A-type particles (IAPs); and class III ERVs (5.4% of the murine genome) show close similarity to spumaviruses (reviewed in reference 3).
Murine ERVs are subject to host gene silencing, and thus, most remain transcriptionally inactive in the genome. DNA methylation of ERV promoters, the site of ERV DNA integration, overall methylation of the host genome (CpG islands), as well as other specific factors can silence ERV transcription (reviewed in reference 4). However, in contrast to humans, where almost all endogenous elements are extinct, in that no provirus is competent for replication, many murine ERVs are still active and capable of replication. Murine endogenous retroviruses that are unable to reinfect mouse host cells on the basis of their cell receptor tropism are termed xenotropic (5) . However, in the context of xenografts, where foreign tissue (i.e., human tumor tissue) has been grafted into an immunocompromised mouse, expressed xenotropic murine endogenous retroviruses (X-MLVs) have the potential to infect and spread in the foreign tissue. This phenomenon was observed as early as the 1970s, when subtype C particles were found to be associated with tumor tissues passaged in mice (6) (7) (8) (9) (10) . Surveys of currently used human cell lines have found that some are positive for MLVs, as a result of either xenografting, cross-contamination, recombination of endogenous retroviruses during passage of cultured cells, or recombination of plasmids in helper cell lines (11) (12) (13) (14) .
Identification of the xenotropic murine leukemia virus-related virus (XMRV) in 2006 (15) and its potential association with prostate cancer and chronic fatigue syndrome (CFS) (15) (16) (17) led to much controversy over whether this virus was a new human pathogen which had crossed species from mice to humans. These findings have been refuted by numerous independent laboratories, debunking any disease association with XMRV (18) (19) (20) (21) . We previously reported that XMRV was a laboratory-derived virus which resulted from recombination between two endogenous proviruses, PreXMRV-1 and PreXMRV-2 (18, 22) , present in Harlan Sprague-Dawley (Hsd) nude mice, in which a human prostate tumor (CWR22) was repeatedly passaged as a xenograft. During this process, progeny of these two proviruses recombined to form a replication-competent xenotropic MLV that was able to spread throughout the human tumor tissue present in the mouse. Consequently, the 22Rv1 cell line derived from the CWR22 xenograft was also positive for XMRV (23) . Since the genome sequence of XMRV from the 22Rv1 cell line was nearly identical to the genome sequences of all published patient XMRVs (24, 25) , it was concluded that contamination by mouse DNA, XMRV, or XMRV RNA/DNA, often due to contamination of common laboratory reagents with mouse DNA, could explain why positive associations between XMRV and CFS or prostate cancer had been previously reported (26) (27) (28) (29) (30) (31) (32) (33) . Indeed, the association between XMRV and human prostate cancer was recently shown by the authors of the original study to be the result of contamination (34) .
Although XMRV is no longer believed to be a human pathogen, the origin of XMRV provides an excellent opportunity to elucidate the mechanisms by which novel replication-competent retroviruses (RCRs) arise via retroviral recombination events. Novel viruses generated via recombination can become human pathogens; human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS, is thought to be the result of zoonotic transmission of a simian immunodeficiency virus (SIV) from chimpanzees (SIVcpz), which itself arose through recombination between two different SIVs (35) . Retroviral recombination can greatly impact the evolution of viral drug resistance, immune evasion, tissue tropism, and expansion of the host range. In addition, recombination between endogenous proviruses can result in the formation of novel RCRs that can infect xenograft tissues in immunocompromised mice. Xenografting of human tumor tissues in nude mice remains an important model system in cancer biology and cancer drug discovery, and the generation and presence of RCRs in these in vivo models can complicate these studies (36) . For example, it was recently shown that PreXMRV-1 contributed to the generation of another RCR, B4rv, during xenograft passaging of another human prostate tumor; furthermore, the PreXMRV-1 envelope was shown to trigger signaling in the host mouse cells that resulted in depletion of smooth muscle cells from blood vessels that infiltrated the tumor, leading to the formation of larger hemorrhagic tumors (37) .
Having identified the two parental proviruses that gave rise to XMRV, we further explored the recombination potential of PreXMRV-1 and PreXMRV-2 and the probability for XMRV, or any RCR, to be generated. In the results presented in this report, we show that while RCRs could be detected, we could not detect any recombinant with the same sequence as XMRV, confirming that the probability of generating XMRV independently is extremely low.
MATERIALS AND METHODS
Plasmids and cell lines. Plasmid VP62 (38) , which expresses a full-length clone of XMRV, was a kind gift from Robert Silverman at the Cleveland Clinic. Construction of plasmid clone PreXMRV-1 was previously described (18) . For the construction of plasmid clone PreXMRV-2, two overlapping halves of the provirus were amplified using flanking primers (C12-1F, C12-4R [22] ) and provirus primers (M19F [5=-TGGCCTTACT GAAAGCTCTCTTCC-3=], 4438R [5=-TACTGAGTCTCTTGGGCAGG A-3=]). The two halves were digested by the SalI restriction enzyme, and the full-length provirus was cloned into pCR-Blunt (Invitrogen).
Human 293T cells (American Type Culture Collection) were maintained at 5% CO 2 and 37°C in Dulbecco's modified Eagle's medium (CellGro) supplemented with 10% fetal calf serum (HyClone), penicillin (50 U/ml; Gibco), and streptomycin (50 g/ml; Gibco). DIG (D17 indicators of gammaretroviruses) is a previously described D17-based canine osteosarcoma cell line that contains an integrated MLVbased reporter virus which contains overlapping FP and GF fragments of the green fluorescent protein (GFP) gene (GF refers to the first two-thirds of gfp, and FP refers to the last two-thirds of gfp) in the 5=and 3= long terminal repeats (LTRs), respectively; gfp is reconstituted upon reverse transcription, and mobilization of the GFP-expressing MLV vector by a replication-competent virus increases the proportion of GFP-positive cells in the culture (39) .
Hsd mouse RNAs and assay for PreXMRV-1 and PreXMRV-2 in vivo transcription. Total DNA from mouse tail snips from 10 Hsd nude mice were prescreened for the presence of PreXMRV-1 and PreXMRV-2 using PCR primer pairs XF6 and C3-4R for PreXMRV-1 and PCR primer pairs C12_1f and 129_1r for PreXMRV-2, as previously described (22) . Three mice that were positive for PreXMRV-2 only and 3 mice that were positive for both PreXMRV-1 and PreXMRV-2 were then sacrificed, and total RNA was extracted from the blood and spleens of these 6 animals, as well as two negative-control mice (BALB/cAnNHsd) obtained from Harlan Laboratories. All animal procedures used in this paper were approved by the Harlan Laboratories Institutional Animal Care and Use Committee.
Isolated RNA was treated for 30 min with DNase I using a Turbo DNA-free kit (Ambion) to remove any remaining genomic DNA (gDNA) contamination. RNAs were further confirmed to be free of gDNA contamination by quantitative PCR with a mouse ␤-actin probe/primer set (40) and Roche LightCycler 480 DNA Probes Master reaction mix with a LightCycler 480 Roche instrument (Roche Diagnostics), according to the manufacturer's instructions.
To determine transcription levels, RNAs were converted to cDNA using random hexamers (SuperScript III First Strand; Invitrogen); reactions with and without reverse transcriptase (RT) further confirmed a lack of DNA contamination. Quantitative PCR was performed using an mRNA ␤-actin primer/probe set (40) and mRNA DPPK (Mus musculus protein kinase, DNA activated, catalytic polypeptide [Prkdc]) primer/ probe set: forward primer 5=-TCAAATGGTCCATTAAGCAAACAA-3=, reverse primer 5=-GCTGCACCTAGCCTCTTGAAA-3=, and probe 5=-FA M-AGCAAGTCACTTTTCAAGCGGCT-3=-TAMARA, where FAM is 6-carboxyfluorescein and TAMRA is 6-carboxytetramethylrhodamine. For PreXMRV-1 detection, the following primer/probe set was used: forward primer 5=-CCTACTACATGTTAAACCGG-3=, reverse primer 5=-A CCCCTGCCCCAATT-3=, and probe 5=-FAM-TATGTGACTGAGACCT GCACC-3=-TAMARA. For PreXMRV-2 detection, the following primer/ probe set was used: forward primer 5=-AAAAGAGACCTGGACACTCT-3=, reverse primer 5=-CCACCTCGTGGAGGATCTTATCTTT-3=, and probe 5=-FAM-TGCCCAGTCAAGACACCTTCGAACTT-3=-TAMARA.
Assay for PreXMRV-1 and PreXMRV-2 ex vivo transcription. PreXMRV-1, PreXMRV-2, or XMRV was transfected (3 independent transfections) by calcium phosphate precipitation into 293T cells plated at 5 ϫ 10 6 cells per 100-mm-diameter dish. Forty-eight hours later, total RNA was extracted using an RNeasy minikit (Qiagen) and treated with DNase I using a Turbo DNA-free kit (Ambion). RNA was converted to cDNA using random hexamers and confirmed to be negative for gDNA contamination by carrying out the reaction in the absence of reverse transcriptase. Total RNA input was normalized using the following mRNA glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primer/ probe set: forward primer 5=-TCCACCCATGGCAAATTC-3=, reverse primer 5=-AGACGCCAGTGGACTC-3=, and probe 5=-FAM-TTTCCAT TGATGACAAGCTTCC-3=-TAMARA. GAPDH cDNA plasmid DNA was used to generate a standard curve to estimate RNA copy numbers. To determine PreXMRV-1 and PreXMRV-2 RNA copy numbers, the following universal envelope primer/probe set was used with VP62 plasmid DNA as the standard curve: forward primer 5=-TCAGGACAAGGGTGG TTTGAG-3=, reverse primer 5=-GGCCCATAATGGTGGATATCA-3=, and probe 5=-FAM-TTAACAGGTCCCCATGGTTCACGACC-3=-TAM ARA.
Western blot analysis. 293T cells transfected with PreXMRV-1, PreXMRV-2, or XMRV were lysed for Western blot analysis at 48 h posttransfection, as previously described (41) . Supernatants were also collected, filtered through a Millex GS 0.45-m-pore-size filter (Nalgene), concentrated 100-fold by centrifugation at 25,000 rpm for 90 min (Surespin; Sorvall), and stored at Ϫ80°C. Cell lysates and viral pellets were assayed using an anti-MLV capsid monoclonal antibody at a 1:200 dilution (42) . Total protein in the cell lysate was assessed using mouse antitu-bulin antibody (Sigma) at a 1:10,000 dilution. The primary antibodies were detected with horseradish peroxidase-labeled goat antimouse secondary antibody at a 1;10,000 dilution (Sigma), and the proteins were visualized using a Western Lightning Plus chemiluminescence reagent kit (PerkinElmer).
Assay for infectious PreXMRV-1 or PreXMRV-2. Filtered viral supernatants obtained at 48 h posttransfection from 293T cells transfected with PreXMRV-1, PreXMRV-2, or XMRV were used to infect DIG cells. Cells were monitored for 1 week to 1 month by fluorescence-activated cell sorter (FACS) analysis for the presence of GFP-positive cells.
PreXMRV-1 and PreXMRV-2 cotransfection. 293T cells plated at 2 ϫ 10 5 cells/well of a 6-well plate were cotransfected with PreXMRV-1 and PreXMRV-2 plasmid DNA via calcium phosphate precipitation. Six independent transfections (transfections A to F) were performed and allowed to expand for 1 week before collecting virus. Cell supernatants were then harvested, filtered, and treated at 37°C with DNase I (5 U) plus DpnI (10 U) for 2.5 h. DNA was extracted (QIAamp DNA blood minikit; Qiagen) from an aliquot of the final supernatant and tested for plasmid or gDNA contamination using PCR primers for GAPDH (intron primers GAPDHfor [5=-CCCCACACACATGCACTTACC-3=] and GAPDHrev [5=-CCTACTCCCAGGGCTTTGATT-3=]) and universal PCR primers for PreXMRV-1 and PreXMRV-2 (primers univPol For [5=-CCGGATCCAGCACCCAGACTTG-3=] and univEnvRev [5=-CACGGG TTAATCTTATCTTTAAGGG-3=]). Target DIG or 293T cells were plated at 2 ϫ 10 5 cells/well of a 60-mm-diameter dish and infected with 2 ml of undiluted supernatant in the presence of 60 l Polybrene (1 mg/ml) from each transfection for 3 h. Cells were then washed with medium and fresh medium was added. Every 3 days, the infected DIG cells were analyzed by FACS for the presence of GFP-positive cells. Concurrently, every 3 days, a portion of the infected 293T cells was lysed for DNA extraction. Primers used for bulk sequencing and single clones were as follows: univRfor (5=-CCCGTGTTCCCAATAAAGCC-3=), midGagrev (5=-CCAGCGATACC GCTTTCCTCCAGTAGCC-3=), midGagfor (5=-GGCTACTGGAGGAA AGCGGTATCGCTGG-3=), univPolrev (5=-CAAGTCTGGGTGCTGGA TCCGG-3=), univPolfor (5=-CCGGATCCAGCACCCAGACTTG-3=), univEnvrev (5=-CACGGGTTAATCTTATCTTTAAGGG-3=), univEnvfor (5=-CCCTTAAAGATAAGATTAACCCGTG-3=), and univRrev (5=-G GCTTTATTGGGAACACGGG-3=).
Nucleotide sequence accession numbers. GenBank accession numbers for the recombinant clones presented in Fig. 5A 
RESULTS
PreXMRV-1 and PreXMRV-2 RNA transcripts are undetectable in the blood and spleen of Hsd nude mice. Previously, it was determined by our groups that the Hsd nude mouse population (which is maintained as an outbred stock) harbors integrated copies of PreXMRV-1 and/or PreXMRV-2, with 53% of the mice being positive for both PreXMRV-1 and PreXMRV-2 (22) . To determine the levels of expression of these proviruses in mouse tissues, total RNA was extracted from the blood and spleen of three Hsd nude mice positive for both proviruses, three Hsd nude mice positive for PreXMRV-2 only, and two BALB/cAnNHsd mice negative for both proviruses. High-level transcripts, such as the ␤-actin transcript (average Ϯ standard deviation, 2,461 Ϯ 1,084 copies/ng cDNA), and rare transcripts, such as the DPPK transcript (average Ϯ standard deviation, 1.9 Ϯ 1.3 copies/ng cDNA), were detected at their expected high and low levels, respectively, from either the blood or spleen of all mice, suggesting that the purified RNA was of good quality and abundant and rare RNA species were well represented ( Fig. 1) . However, primer/ probe sets specific for PreXMRV-1 or PreXMRV-2 were unable to detect any PreXMRV-1 or PreXMRV-2 RNA transcripts (Ͻ0.2 copies/ng cDNA). Assuming, on average, 10 pg of total RNA per cell (43), PreXMRV-1 and PreXMRV-2 were present at less than Ͻ0.002 copy/cell in either the spleen or blood.
PreXMRV-1 and PreXMRV-2 are noninfectious. Sequence analysis of PreXMRV-1 indicated that a 16-nucleotide (nt) deletion leading to a frameshift in the capsid gene and a single-nucleotide insertion leading to a frameshift in pol rendered this virus replication incompetent (18) . However, the gag-pro-pol and env reading frames are open in PreXMRV-2, suggesting that it has the potential to be replication competent (18) . To determine their replication potential, proviral molecular clones of PreXMRV-1, PreXMRV-2, and XMRV, as a control, were independently transfected into 293T cells. Using Western blot analysis, we were unable to detect capsid proteins in either the cell lysates or viral pellets from PreXMRV-2; however, we were able to detect the presence of XMRV ( Fig. 2A ). Since PreXMRV-1 has a frameshift mutation in the capsid gene, only the first 101 amino acids of the capsid (total length, 263 amino acids) would be translated, and the capsid may not react with the anti-MLV capsid monoclonal antibody. However, despite the lack of protein detection on the Western blot, both PreXMRV-1 and PreXMRV-2 RNA were found in 293T cells at similar levels following transfection (Fig. 2B) . A real-time reverse transcription-PCR primer/probe set designed to detect env sequences was used to detect both unspliced and spliced tran- scripts. PreXMRV-1 and PreXMRV-2 transcripts were detected at levels of 38% and 30%, respectively, compared to the level of XMRV. Of note, the XMRV positive control was transcribed from the cytomegalovirus (CMV) promoter, whereas PreXMRV-1 and PreXMRV-2 were transcribed from their LTR promoters. Regardless, the results suggest that there was a posttranscriptional block to stable expression of viral capsid protein from the PreXMRV-2 provirus, the reasons for which may include aberrant splicing, inhibition of translation, and/or instability of the protein.
To use a more sensitive assay to test for viral production, supernatants from the PreXMRV-1-, PreXMRV-2-, and XMRVtransfected 293T cells were used to infect DIG reporter cells. Briefly, DIG cells contain a ⌿-positive MLV (⌬gag, ⌬pol, and ⌬env) with partially redundant portions of the gfp gene in both LTRs (shown in Fig. 2C as GF and FP). In the presence of a replicating virus, these RNA transcripts are packaged and reconstitute GFP upon reverse transcription. The replicating virus also serves as a helper virus to mobilize the new GFP-positive provirus and subsequently detect GFP expression throughout the DIG cell culture. Thus, DIG cells treated with supernatants from cells transfected with PreXMRV-1, PreXMRV-2, or XMRV were monitored for increases in GFP expression and fluorescence by FACS analysis from 1 week to 1 month. A high proportion of DIG cells infected with XMRV (50%) was GFP positive, confirming that XMRV is replication competent; however, GFP-positive cells could not be detected after infection with PreXMRV-1 or PreXMRV-2 ( Fig.  2C) , indicating that PreXMRV-1 and PreXMRV-2 alone were not able to generate infectious virions. Similar results were previously obtained by transfection of another XMRV-susceptible cell line with cloned full-length PreXMRV-2 provirus (22) (data not shown).
Recombination potential of PreXMRV-1 and PreXMRV-2. To assess the recombination potential of PreXMRV-1 and PreXMRV-2, 293T cells were cotransfected with their proviral clones. One week later, supernatants were harvested and used to infect fresh 293T or DIG target cells (Fig. 3) . Supernatant was harvested at 1 week posttransfection to give the cultures ample time to produce virus. FACS analysis of the DIG cell cultures was performed to monitor the appearance of GFP-positive cells, indicating the production of an RCR. At 3 days postinfection, there was a negligible GFP signal, but at 6 days postinfection, 4 to 16% of Relative env RNA copy numbers normalized to GAPDH copy numbers for XMRV, PreXMRV-1, and PreXMRV-2. Quantitative PCR using a universal env primer/probe set able to detect VP62, PreXMRV-1, and PreXMRV-2 was performed after conversion of total cytoplasmic RNA to cDNA using random hexamer primers. the cells were GFP positive in the 6 independent infections (infections A to F), and at 10 days postinfection, 64 to 73% of cells were GFP positive. Thus, recombination between PreXMRV-1 and PreXMRV-2 in each culture gave rise to one or more RCRs that mobilized the MLV vector in the DIG cells to reconstitute the gfp gene. Population sequencing analysis of proviruses. Since each of the six replicates likely contained numerous viral variants, we amplified different regions of the proviruses by PCR and directly sequenced the PCR products to obtain an average sequence of the proviral population. The population sequencing was initially performed for a region spanning the polymerase, connection subdomain, and RNase H domain of pol, as well as env (Fig. 4) . Figure  4 plots the percentage of PreXMRV-1 and PreXMRV-2 signals from the sequencing chromatograms at each position where PreXMRV-1 and PreXMRV-2 differ in nucleotide sequence. The population sequencing plots for the pol regions in Fig. 4A show that infections A, B, and D contained pools of viral variants, while infections E and F likely contained only 2 viral variants that differed at a single nucleotide position at the crossover site. For infection C, only one viral variant was detectable by bulk sequencing, with the crossover occurring in a region of nucleotide similarity between PreXMRV-1 and PreXMRV-2. Interestingly, for env in Fig. 4B , infections A, C, D, and F showed that all the viral variants in the population shared 100% sequence identity with PreXMRV-1, while infections B and E showed that the viral variants shared some short stretches of identity with PreXMRV-2. These results show that, while env from PreXMRV-1 is predominantly present in the RCRs, replacement of some of these regions of PreXMRV-1 env with the homologous regions of PreXMRV-2 env is compatible with preserving PreXMRV-1 env function.
Sequence analysis of cloned PCR products confirms population sequencing data. Since minor viral variants would not be detectable by population sequencing, single PCR-amplified molecules were cloned and sequenced for all infections across the entire genome. The genome was divided into 4 regions starting with R/U5 to the beginning of pro, the beginning of pro to the conserved YVDD box in pol, the YVDD box in pol to the end of the integrase (IN)/start of env, and the start of env to U3/R. Figure 5 shows individual clones sequenced for each region and for each infection (infections A to F), plotted using the Hypermut HIV sequence database to facilitate visualization of PreXMRV-1 and PreXMRV-2 sequence differences (http://www.hiv.lanl.gov /content/sequence/HYPERMUT/hypermut.html). For all clones, a minimum of 9 nt of sequence identity was present at the site of a crossover between PreXMRV-1 and PreXMRV-2. All of the analyzed clones exhibited recombination events within the region from R/U5 to the beginning of gag (Fig. 5A and 6A ). All clones from infections D, E, and F contained sequences matching the XMRV sequence 100%, indicating that these clones used the same 27-nt window in the untranslated region (UTR) upstream of the Gag start codon to cross over between PreXMRV-1 and B. PreXMRV-2 (Fig. 6A ). The precise location within the 27-nt window in which the crossover occurred cannot be determined, since the two parent viruses have the same nucleotide sequence in this region. A total of 6 different recombination junctions was observed among the 6 infections for this region ( Fig. 5A and 6A ). As shown in Fig. 5B , all clones from all infections maintained 100% PreXMRV-2 sequence identity in the region from the beginning of protease to the YVDD box in pol. For the region starting with the YVDD box in pol to the end of IN (Fig. 5C and 6B ), 14 different recombination junctions were observed among the 6 infections, with only one clone in infection B using the same 46-nt region of identity between PreXMRV-1 and PreXMRV-2 that XMRV used to undergo a crossover event. Lastly, the region from the end of IN to U3/R ( Fig. 5D and 6C ) showed no clones with 100% identity to XMRV. Most clones maintained the PreXMRV-1 sequence for all of env and U3/R, with clones from infections B and E containing stretches of PreXMRV-2 sequence. A total of 6 crossover events was observed among the clones from the 6 infections (Fig. 6C) . In infection C, one minor recombinant (1 of 6) was detected by sequencing of cloned PCR products (Fig. 5C ) but was not detected by bulk sequencing (Fig. 4A) . With the exception of the results for this clone, the results of the single-clone sequencing analysis matched the population sequencing data, indicating that the population sequencing results were generally representative of those for the viral variants present in each population. Additionally, analysis of population sequencing data from days 3, 6, and 10 for reverse transcriptase (RT) or env in the recombinants did not vary (data not shown), suggesting that selection for the predominant A. B. RCRs in each infection had already occurred by day 3. Finally, these data show that the recombinants preferred the gag and 5= half of pol from PreXMRV-2 and the LTR, 3= half of pol (including IN), and env from PreXMRV-1.
C. D.
Estimation of the probability of generating an RCR with the same sequence as XMRV. On the basis of data from the analyzed recombinant clones, the probability that a recombinant with the same genotype as XMRV would be generated can be calculated by asking how many of the recombinants used the same regions of identity as XMRV to undergo a crossover event (Fig. 7) . None of the recombinant clones used crossover 1, 2, 3, or 4 that XMRV used in env (Ͻ1/34 total clones analyzed), and only 1/26 total clones used the same region of identity in crossover 5 in pol as XMRV. A total of 12/26 clones used the same identity region in the UTR before the start of gag that XMRV used. Multiplying these numbers together (12/26 ϫ 1/26 ϫ Ͻ1/34 ϫ Ͻ1/34 ϫ Ͻ1/34 ϫ Ͻ1/34), on the basis of the results obtained for the clones analyzed, the probability that XMRV would be generated is Ͻ1.3 ϫ 10 Ϫ8 . However, it must be noted that the actual probability is likely to be much lower, in view of the following considerations: (i) the probability that an Hsd nude mouse possesses both PreXMRV-1 and PreXMRV-2 is approximately 50%; (ii) the probability that PreXMRV-1 and PreXMRV-2 would be transcribed in the same mouse cell at the same time is unknown but is likely to be low, on the basis of the undetectable levels of RNA transcripts in blood and spleen; (iii) the probability of copackaging of the PreXMRV-1 and PreXMRV-2 RNAs to form a heterozygous virion is low, since MLVs have a lower frequency of heterozygous virion formation than expected by random copackaging (44, 45) ; (iv) the probability that proteins expressed from PreXMRV-1 and PreXMRV-2 do not complement to generate an infectious virus, and a third helper virus is needed to copackage the two parental genomes is low; and (v) the probability for a heterozygous virus to infect xenograft tissue, recombine to form an RCR, and spread in the xenograft is unknown but is likely to be low, since XMRV was not detected for at least three passages in nude mice (18) , constituting several months of xenograft passage in mice.
DISCUSSION
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impediments to the formation of XMRV and its spread in the human tumor tissues. First, undetectable levels of PreXMRV-1 or PreXMRV-2 RNA in the Hsd nude mouse blood or spleen suggest that these proviruses are rarely transcribed. Second, neither PreXMRV-1 nor PreXMRV-2 alone can form infectious virions, suggesting that either their expressed proteins complement each other to form infectious virions or they undergo recombination to generate an RCR. As previously proposed (22) , assuming that they do not complement each other to from infectious virions, a third endogenous provirus may have been needed as a helper virus to copackage PreXMRV-1 and PreXMRV-2 RNAs so that an RCR could be generated. -2 ................G..T........T..C..A.AA.....A....................C.......................G...AC...G.....C........................ XMRV template switch #1 XMRV template switch #1 
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C Q K Q V K Y L G Y L L R E G Q R W L T E A R K E T V M G Q P V P K T P R Q L R E F L G PreXMRVGACGGCAGGCTTCTGCCGCCTCTGGATCCCTGGGTTTGCGGAAATGGCGGCCCCCTTATACCCGCTCACCAAGACTGGGACTCTGTTTAAGTGGGGCCCAGATCAGCAGAGGGCCTATCAAGAAATCAAA T A G F C R L W I P G F A E M A A P L Y P L T K T G T L F K W G P D Q Q R APreXMRV-1 CAGGCCCTCCTGACGGCCCCCGCCCTGGGATTGCCAGACTTGACCAAGCCCTTTGAACTTTTTGTCGATGAAAAGCAGGGCTACGCCAAAGGGGTCCTAACGCAGAAACTGGGACCTTGGCGCCGGCCTG Q A L L T A P A L G L P D L T K P F E L F V D E K Q G Y A K G V L T Q K L G P W R R P PreXMRV
PreXMRV-1 TGGCCTACCTGTCCAAAAAGCTGGACCCAGTGGCAGCCGGGTGGCCCCCCTGCTTACGGATGGTAGCAGCCATTGCCGTTCTGACAAAGGATGCAGGCAAACTAACGATGGGACAGCCGTTAGTCATCTT
V A Y L S K K L D P V A A G W P P C L R M V A A I A V L T K D A G K L T M G Q P L V I L PreXMRV
PreXMRV-1 GGCCCCCCATGCGGTAGAAGCACTGGTCAAACAACCCCCTGACCGTTGGCTATCCAATGCCCGCATGACCCACTATCAGGCAATGCTCCTGGATACAGACCGGGTTCAGTTCGGACCGGTGGTGGCCCTC
A P H A V E A L V K Q P P D R W L S N A R M T H Y Q A M L L D T D R V Q F G P V V A L PreXMRV1 AACCCGGCCACCCTGCTCCCCCTACCGGAAAAGGAAGCCCCCCATGACTGCCTCGAGATCTTGGCTGAGACGCACGGAACCAGACCGGACCTCACGGACCAGCCCATCCCAGACGCTGATTACACTTGGT N P A T L L P L P E K E A P H D C L E I L A E T H G T R P D L T D Q P I P D A D Y T W PreXMRV
PreXMRV-1 ACACAGATGGAAGCAGCTTCCTACAAGAAGGACAACGGAGAGCTGGAGCAGCGGTGACTACTGAGACCGAGGTAATCTGGGCGAGGGCTCTGCCGGCTGGAACATCCGCCCAACGAGCCGAACTGATAGC Y T D G S S F L Q E G Q R R A G A A V T T E T E V I W A R A L P A G T S A Q R A E L I A

PreXMRV
PreXMRV-1 ACTCACCCAAGCCTTAAAGATGGCAGAAGGTAAGAAGCTAAATGTTTACACTGATAGCCGCTATGCCTTCGCCACGGCCCATGTCCATGGAGAAATATATAGGAGGCGAGGGTTGCTGACCTCAGAAGGC
L T Q A L K M A E G K K L N V Y T D S R Y A F A T A H V H G E I Y R R R G L L T S E G PreXMRVGGAAACACTCCTAAGGGTCAGGGCCCCTGTTTTGATTCCTCAGTGGGCTCCGGTAGCATCCAGGGTGCCACACCGGGGGGTCGATGCAACCCCCTAGTCCTAGAATTCACTGACGCGGGTAAAAGGGCCA G N T P K G Q G P C F D S S V G S G S I Q G A T P G G R C N P L V L E F T D A G K R A .GCTGGGATGCCCCCAAAACATGGGGACTAAGACTGTATCGATCCACTGGGGCCGACCCGGTGACCCTGTTCTCTCTGACCCGCCAGGTCCTCAATGTAGGGCCCCGCGTCCCCATTGGGCCTAATCCCGT S W D A P K T W G L R L Y R S T G A D P V T L F S L T R Q V L N V G P R V P I G
GATCACTGAACAGCTACCCCCCTCCCAACCCGTGCAGATCATGCTCCCCAGGCCTCCTCGTCCTCCTCCTTCAGGCGCGGCCTCTATGGTGCCTGGGGCTCCCCCGCCTTCTCAACAACCTGGGACGGGA
I T E Q L P P S Q P V Q I M L P R P P R P P P S G A A S M V P G A P P P S Q Q P G T G 
CTTACTCCAACCATACCTCTGCCCCGGCTAACTGCTCCGTGACCTCCCAACACAAGCTGACCCTGTCCGAAGTGACCGGGCAGGGACTCTGCATAGGAGCAGTTCCCAAAACCCATCAGGCCCTGTGTAA T Y S N H T S A P
A N C S V T S Q H K L T L S E V T G Q G L C I G A V P K T H Q
TACCACCCAGAAGACGAGCGACGGGTCCTACTATTTGGCCTCTCCCGCCGGGACCATTTGGGCTTGCAGCACCGGGCTCACTCCCTGTCTATCTACTACTGTGCTTAACTTAACCACTGATTACTGTGTC T T Q K T S D G S Y Y L A S P A G T I W A C S T G L T P C L S T T V L N L T T D
C.
FIG 6 continued
The low undetectable transcript level of PreXMRV-1 and PreXMRV-2 in blood and spleen is not unusual, since most murine endogenous proviruses are transcriptionally silenced during early embryonic stages and usually remain inactive in the host genome throughout the life of the mouse. However, the possibility that PreXMRV-1 and PreXMRV-2 are transcriptionally active in some mouse tissue or at some stage in the life of the mouse cannot be excluded. It is also possible that treatment of Hsd nude mice with androgens during the xenograft passaging led to the activation of these proviruses, thereby contributing to the formation of XMRV.
We expected PreXMRV-1 to be replication defective because it has a deletion/frameshift mutation in gag and an insertion/frameshift mutation in pol. However, we were surprised that PreXMRV-2 is also replication defective, even though its gag, pol, and env reading frames are open and have no obvious missense mutations. Furthermore, PreXMRV-2 did not express any detectable capsid protein in transfected 293T cells, even though PreXMRV-2 RNA could be detected at about 30% of the level observed for VP62, an XMRV molecular clone that transcribes viral RNA from a CMV promoter (38) . PreXMRV-2 RNA was quantified using a primer/probe set targeting env and can detect both spliced and unspliced RNA; thus, it is possible that Gag was not expressed because of aberrant splicing that results in the loss of full-length RNA, which is used to express Gag-Pol, but not spliced RNA, which is used to express Env. Other possible reasons for the lack of Gag expression include suppression of Gag translation or microRNA-induced degradation of full-length RNA.
Our results showed that even though PreXMRV-1 and PreXMRV-2 were replication defective, they could readily recombine to generate RCRs. Although recombination of the endogenous proviruses in mice most likely occurs only during reverse transcription, the RCRs analyzed in this experiment could have resulted from recombination during transfection or reverse transcription. It is likely that recombination events can occur anywhere in the viral genome during either transfection or reverse transcription and RCRs with the same structures can form regardless of the mechanism of recombination. Another possibility is that in mice a third provirus acts as a helper virus to copackage PreXMRV-1 and PreXMRV-2 RNAs, which is a prerequisite to their recombination during reverse transcription. However, since there are no potential helper viruses in DIG cells, recombination during transfection was required to generate the RCRs. Regardless of the mechanism, the recombinants generated in vivo and in this cell culture system were selected for their ability to replicate efficiently and become RCRs; hence, the RCRs selected in this study reflect the RCRs that are likely to be subjected to selection in mice and provide insights into the capacity of PreXMRV-1 and PreXMRV-2 to generate RCRs.
The structures of the RCRs indicate that all of the recombinants had a crossover within a 415-nt selected recombination zone within the 5= UTR before the start of gag and another crossover within a 982-nt selected recombination zone in pol. The term "selected recombination zone" does not imply that this region was a hot spot for RT template switching. Recombination events in these two zones were strongly selected and were presumably essential for the formation of the RCRs. Thus, there was a strong selection for the recombinants to maintain the LTR, 3= pol (Cterminal portions of RT and IN), and env of PreXMRV-1 origin and the gag, pro, and 5= pol (N-terminal half of RT) of PreXMRV-2 origin. The reason for the selection of the PreXMRV-1 LTR is not clear, since the PreXMRV-2 LTR appears to be functional in directing transcription in transfected 293T cells. While the selection for PreXMRV-2 gag-pol was expected because of mutations in gag and the beginning of pol in the PreXMRV-1 genome, it appears that the PreXMRV-2 IN may be defective or poorly functional in the recombinants since PreXMRV-1 IN was strongly selected. The attachment sites for integration in PreXMRV-1, which are present in all RCRs, and PreXMRV-2 are identical, making it unlikely that these elements contributed to the selection of PreXMRV-1. PreXMRV-1 and PreXMRV-2 IN primary sequences are quite divergent and share only 84% nucleotide sequence identity (87% amino acid sequence identity). It is possible that the PreXMRV-2 IN is either defective or has low activity, leading to the selection of PreXMRV-1 IN; however, additional studies are needed to test this hypothesis.
Closer examination of the 5= UTR shows that all RCRs had a recombination junction within the 415-nt selected recombination 
FIG 7
Selected recombination zones and the probability of generating a recombinant with exactly the same sequence as XMRV. A 415-nt region in the 5= UTR and a 982-nt region in RT are defined as the selected recombination zones. A crossover within each of these selected recombination zones was observed in all RCRs and is postulated to be essential for formation of an RCR. Using the data from the recombinants from infections A to F, the number of recombinants that used the same region for any of the 6 crossover switches between PreXMRV-1 and PreXMRV-2 that generated XMRV is listed (red boxes). For example, in the 5= UTR, 15 of the 26 clones analyzed used the same region as XMRV for a crossover. Multiplying together the number of clones that used the same homology region as XMRV for crossover events (12/26 ϫ 1/26 ϫ Ͻ1/34 ϫ Ͻ1/34 ϫ Ͻ1/34 ϫ Ͻ1/34), the probability of generating XMRV is Ͻ1.3 ϫ 10 Ϫ8 . Dark gray shading, PreXMRV-1 sequences; light gray shading, PreXMRV-2 sequences.
